Loading video...

Video Failed to Load

Go Home

All-In Interview: FDA Commissioner Dr. Marty Makary david friedberg sits down with Dr. Marty Makary for a comprehensive convo on his overhaul of the FDA: -- Safely accelerating clinical trials -- US vs China in biotech -- Fixing the Food Pyramid -- Rethinking vaccines with common sense -- Cutting...

theallinpod's profile picture

The All-In Podcast

590,369 subscribers

152,456 views • 7 months ago •via X (Twitter)

Health & WellnessScience & Technology
LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

FDA Commissioner Dr. Marty Makary confirms the agency uncovered suppressed data on myocarditis risks from COVID vaccines in young, healthy individuals—data that was withheld when it should have triggered immediate action. In a candid interview with Megyn Kelly, Makary revealed the FDA responded by issuing a strong warning and demanding clinical trials before approving future boosters for young, healthy kids. His stance reflects a shift: "We’re not going to rubber stamp blindly." With 85% of healthcare workers rejecting the last booster, Makary’s focus is on accountability moving forward: "I’m not interested in looking back. I’m interested in success." The question remains: What else was hidden—and who will be held responsible?
1:08

FDA Commissioner Dr. Marty Makary confirms the agency uncovered suppressed data on myocarditis risks from COVID vaccines in young, healthy individuals—data that was withheld when it should have triggered immediate action. In a candid interview with Megyn Kelly, Makary revealed the FDA responded by issuing a strong warning and demanding clinical trials before approving future boosters for young, healthy kids. His stance reflects a shift: "We’re not going to rubber stamp blindly." With 85% of healthcare workers rejecting the last booster, Makary’s focus is on accountability moving forward: "I’m not interested in looking back. I’m interested in success." The question remains: What else was hidden—and who will be held responsible?

Camus

33,512 views • 10 months ago

Patrick Bet-David just asked the new FDA Commissioner Dr. Marty Makary the one question everyone has been thinking about: How do you take on an industry that spent $713 million lobbying in a single year when you’re trying to reform the patent system that keeps drug prices so high? Dr. Makary confirms bipartisan patent-reform bills (including Rand Paul’s) are already in Congress, the FDA is publicly supporting the need for change, but the decisive votes happen where the campaign money flows heaviest. PBD: “Imagine how many members of Congress are quietly told: don’t touch this one.” This 1:45 clip is the most direct explanation yet of the real obstacles to lower drug costs, straight from the top of the FDA. Worth the watch and the share.
1:45

Patrick Bet-David just asked the new FDA Commissioner Dr. Marty Makary the one question everyone has been thinking about: How do you take on an industry that spent $713 million lobbying in a single year when you’re trying to reform the patent system that keeps drug prices so high? Dr. Makary confirms bipartisan patent-reform bills (including Rand Paul’s) are already in Congress, the FDA is publicly supporting the need for change, but the decisive votes happen where the campaign money flows heaviest. PBD: “Imagine how many members of Congress are quietly told: don’t touch this one.” This 1:45 clip is the most direct explanation yet of the real obstacles to lower drug costs, straight from the top of the FDA. Worth the watch and the share.

Camus

45,052 views • 8 months ago

“If the FDA had enforced the law, pharma would owe $19 billion.” The FDA under Marty Makary is officially forcing drug companies to post all clinical trial results, not just the ones that make drugs look effective. “In 2007, Congress passed a law if you run a drug study in America, you have to post the results, all of them, not just the ones that worked.” “If a company runs 10 studies and only 2 work… and they only show the good ones and suppress the bad ones, then the doctor and the patient are misled.” “The fine for breaking this law is about $13,000 a day per trial omitted.” “How many fines has the FDA collected in 19 years? Zero.” “3 weeks ago, Dr. Marty Makary put out an announcement that Pharma has been suppressing unfavorable clinical trial results.” “He sent messages to 2,200 companies saying, ‘We know you’re out of compliance and you have to fix it.’” Dr. Eric Berg DC
2:34

“If the FDA had enforced the law, pharma would owe $19 billion.” The FDA under Marty Makary is officially forcing drug companies to post all clinical trial results, not just the ones that make drugs look effective. “In 2007, Congress passed a law if you run a drug study in America, you have to post the results, all of them, not just the ones that worked.” “If a company runs 10 studies and only 2 work… and they only show the good ones and suppress the bad ones, then the doctor and the patient are misled.” “The fine for breaking this law is about $13,000 a day per trial omitted.” “How many fines has the FDA collected in 19 years? Zero.” “3 weeks ago, Dr. Marty Makary put out an announcement that Pharma has been suppressing unfavorable clinical trial results.” “He sent messages to 2,200 companies saying, ‘We know you’re out of compliance and you have to fix it.’” Dr. Eric Berg DC

MAHA Action

15,876 views • 4 months ago

🚨 NOW: President Trump appoints pro-MAHA Dr. Heidi Overton as the next FDA COMMISSIONER, replacing Marty Makary She is STRONGLY backed by RFK Jr. 👏🏻 "Heidi is “ALWAYS RIGHT,” Secretary Kennedy recently said in the Oval Office! We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES." "Dr. Overton was a prestigious White House Fellow in my First Term, is a Board-Certified Physician in Public Health and General Preventive Medicine, and holds a Ph.D. in Clinical Investigations from the Johns Hopkins University. She is SMART and RESPECTED by all! Dr. Heidi will work with Secretary Kennedy and Dr. Oz to RAPIDLY deliver on my priorities of FASTER Cures, INCREASED American Innovation, MAJOR Clinical Trial Reforms, LOWER Drug Prices, and even more MAHA WINS!" "Dr. Overton will continue putting AMERICA FIRST, and creating a HEALTHY AMERICA. Congratulations to Dr. Heidi Overton! President DONALD J. TRUMP"
0:26

🚨 NOW: President Trump appoints pro-MAHA Dr. Heidi Overton as the next FDA COMMISSIONER, replacing Marty Makary She is STRONGLY backed by RFK Jr. 👏🏻 "Heidi is “ALWAYS RIGHT,” Secretary Kennedy recently said in the Oval Office! We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES." "Dr. Overton was a prestigious White House Fellow in my First Term, is a Board-Certified Physician in Public Health and General Preventive Medicine, and holds a Ph.D. in Clinical Investigations from the Johns Hopkins University. She is SMART and RESPECTED by all! Dr. Heidi will work with Secretary Kennedy and Dr. Oz to RAPIDLY deliver on my priorities of FASTER Cures, INCREASED American Innovation, MAJOR Clinical Trial Reforms, LOWER Drug Prices, and even more MAHA WINS!" "Dr. Overton will continue putting AMERICA FIRST, and creating a HEALTHY AMERICA. Congratulations to Dr. Heidi Overton! President DONALD J. TRUMP"

Eric Daugherty

36,374 views • 9 days ago

Megyn Kelly & FDA Chief on COVID Accountability In a striking interview, Megyn Kelly pressed FDA Commissioner Dr. Marty Makary on a critical question: Was there a deliberate cover-up of COVID vaccine risks by agencies like the FDA and NIH? Kelly suggested officials may have "scrubbed the record" before departing, but questioned if any evidence of misconduct remained. Dr. Makary’s response was a stunning admission. He confirmed that officials were, in fact, "sitting on data" concerning myocarditis in young, healthy individuals—and failed to act in a timely manner. The FDA's response, he stated, was to issue a strong warning and change its policy. Notably, the agency will no longer offer a "rubber stamp" for annual vaccines for healthy children without clinical trial data—a direct result of the loss of trust, evidenced by 85% of healthcare workers rejecting the last booster. While Dr. Makary pivoted to a forward-looking stance, the takeaway is clear: A top official has publicly acknowledged that federal health agencies withheld vital safety information from the public. The conversation on accountability has officially begun.
1:08

Megyn Kelly & FDA Chief on COVID Accountability In a striking interview, Megyn Kelly pressed FDA Commissioner Dr. Marty Makary on a critical question: Was there a deliberate cover-up of COVID vaccine risks by agencies like the FDA and NIH? Kelly suggested officials may have "scrubbed the record" before departing, but questioned if any evidence of misconduct remained. Dr. Makary’s response was a stunning admission. He confirmed that officials were, in fact, "sitting on data" concerning myocarditis in young, healthy individuals—and failed to act in a timely manner. The FDA's response, he stated, was to issue a strong warning and change its policy. Notably, the agency will no longer offer a "rubber stamp" for annual vaccines for healthy children without clinical trial data—a direct result of the loss of trust, evidenced by 85% of healthcare workers rejecting the last booster. While Dr. Makary pivoted to a forward-looking stance, the takeaway is clear: A top official has publicly acknowledged that federal health agencies withheld vital safety information from the public. The conversation on accountability has officially begun.

Camus

398,461 views • 9 months ago

Dr. Marty Makary is raising major concerns about a recent mRNA flu shot after claiming the clinical trial showed no measurable benefit for seniors, the age group typically most vulnerable to severe flu outcomes. Makary says the data from the trial failed to demonstrate effectiveness and argues that the FDA should not approve a product that, in his view, did not perform in the population it aims to protect. He warns that automatically approving new technologies without solid evidence “makes a mockery of science,” calling for stricter transparency and higher standards in evaluating mRNA-based vaccines. Makary emphasizes that regulatory decisions should be driven by proven results—not assumptions, pressure, or expectations.
0:31

Dr. Marty Makary is raising major concerns about a recent mRNA flu shot after claiming the clinical trial showed no measurable benefit for seniors, the age group typically most vulnerable to severe flu outcomes. Makary says the data from the trial failed to demonstrate effectiveness and argues that the FDA should not approve a product that, in his view, did not perform in the population it aims to protect. He warns that automatically approving new technologies without solid evidence “makes a mockery of science,” calling for stricter transparency and higher standards in evaluating mRNA-based vaccines. Makary emphasizes that regulatory decisions should be driven by proven results—not assumptions, pressure, or expectations.

Died Suddenly

14,860 views • 9 months ago

A seismic shift in global health policy is underway. The U.S. FDA Commissioner, Dr. Marty Makary, has announced a complete overhaul of America's foundational health rules—changes that will likely impact food and drug standards far beyond its borders. First, the iconic Food Pyramid, a symbol of nutritional guidance for decades, is being rewritten. The new evidence-based guidelines will cease demonizing natural fats and finally target the real issue: ultra-processed foods, which dominate modern diets globally. But the revolution doesn't stop there. The FDA is aggressively accelerating drug approvals, using AI and computational models to slash approval times from years to weeks. They are also dramatically reducing redundant animal testing, a move that will reshape biomedical research. The ambitious goal? To fast-track potential cures for Alzheimer's, PTSD, and Type 1 diabetes, and to pioneer a universal flu shot. Why does this matter to you? The decisions made in Washington often set the precedent for global health policy, pharmaceutical development, and nutritional science worldwide. This is a pivotal moment for international public health.
1:28

A seismic shift in global health policy is underway. The U.S. FDA Commissioner, Dr. Marty Makary, has announced a complete overhaul of America's foundational health rules—changes that will likely impact food and drug standards far beyond its borders. First, the iconic Food Pyramid, a symbol of nutritional guidance for decades, is being rewritten. The new evidence-based guidelines will cease demonizing natural fats and finally target the real issue: ultra-processed foods, which dominate modern diets globally. But the revolution doesn't stop there. The FDA is aggressively accelerating drug approvals, using AI and computational models to slash approval times from years to weeks. They are also dramatically reducing redundant animal testing, a move that will reshape biomedical research. The ambitious goal? To fast-track potential cures for Alzheimer's, PTSD, and Type 1 diabetes, and to pioneer a universal flu shot. Why does this matter to you? The decisions made in Washington often set the precedent for global health policy, pharmaceutical development, and nutritional science worldwide. This is a pivotal moment for international public health.

Camus

24,714 views • 9 months ago

MAKARY: “We’re not going to blindly rubber-stamp vaccines for teenagers every year in perpetuity. Those days are OVER.” FDA Commissioner Dr. Marty Makary just dropped the hammer on Big Pharma: their booster-for-life model is done. Makary took aim at the never-ending COVID shot agenda—and made it clear the rules have changed. “We’re bringing back gold-standard science and common sense to the entire approval process for vaccines,” he said. Then he called out the absurdity head-on: “The theory that a young, healthy girl needs 50 or 60 COVID boosters over her lifetime is unproven.” “We don’t know with any scientific certainty that that’s necessary.” Makary said future authorizations will depend on hard data—not Pharma lobbying: “We’ve told the companies: if you present updated clinical trial data showing that young, healthy Americans need and benefit from a safe vaccine—we’ll act.” “But we’re not going to rubber-stamp vaccines for teenagers every year forever. Those days are over.”
0:52

MAKARY: “We’re not going to blindly rubber-stamp vaccines for teenagers every year in perpetuity. Those days are OVER.” FDA Commissioner Dr. Marty Makary just dropped the hammer on Big Pharma: their booster-for-life model is done. Makary took aim at the never-ending COVID shot agenda—and made it clear the rules have changed. “We’re bringing back gold-standard science and common sense to the entire approval process for vaccines,” he said. Then he called out the absurdity head-on: “The theory that a young, healthy girl needs 50 or 60 COVID boosters over her lifetime is unproven.” “We don’t know with any scientific certainty that that’s necessary.” Makary said future authorizations will depend on hard data—not Pharma lobbying: “We’ve told the companies: if you present updated clinical trial data showing that young, healthy Americans need and benefit from a safe vaccine—we’ll act.” “But we’re not going to rubber-stamp vaccines for teenagers every year forever. Those days are over.”

The Vigilant Fox 🦊

218,342 views • 1 year ago

FDA Commissioner Dr. Marty Makary and David Friedberg explain why they declined the Hepatitis B vaccine for their newborns. Both say the decision felt socially unacceptable, even though it was thoughtful and informed. David Friedberg: “We talked about the Hep B vaccine, which we declined on the day he was born.” “We have no Hep B exposure in our household.” “We don’t need it.” “You recognize there may be some unfounded principles at play here, I should not be doing this.” “We make a difficult decision against the tide and the recommendations and suddenly you're in the social conflict with people around you.” Dr. Marty Makary: “You feel like you're a fugitive of the law.” “We went through the same thing.” “We were offered the Hepatitis B shot… and we declined.” “When you ask the question, immediately you get this sort of anti-vax label… this sort of McCarthyism.
2:30

FDA Commissioner Dr. Marty Makary and David Friedberg explain why they declined the Hepatitis B vaccine for their newborns. Both say the decision felt socially unacceptable, even though it was thoughtful and informed. David Friedberg: “We talked about the Hep B vaccine, which we declined on the day he was born.” “We have no Hep B exposure in our household.” “We don’t need it.” “You recognize there may be some unfounded principles at play here, I should not be doing this.” “We make a difficult decision against the tide and the recommendations and suddenly you're in the social conflict with people around you.” Dr. Marty Makary: “You feel like you're a fugitive of the law.” “We went through the same thing.” “We were offered the Hepatitis B shot… and we declined.” “When you ask the question, immediately you get this sort of anti-vax label… this sort of McCarthyism.

End Tribalism in Politics

18,838 views • 7 months ago

For the first episode of Development & Research, I spoke with Meri Beckwith on: • being a patient in an incompetently-run clinical trial, • how many drug trials fail b/c of bad paperwork, • who benefits when trials are expensive, • just how quickly biotech founders lose control to investors, • why no one is picking up the billion-dollar bills on the sidewalk. Timestamps: 00:01:51 - "Eroom's Law" 00:03:12 - The gap between new science and new medicine 00:04:51 - Clinical trials: the patient experience 00:08:19 - The lifecycle of a biotech startup 00:10:22 - Clinical Research Organizations 00:13:19 - 10% of trials fail b/c of clerical errors 00:17:27 - Lindus Health (Meri's Series-B startup) 00:19:03 - Recruiting more patients won't save badly-planned trials 00:23:36 - Meri's skepticism of international trials 00:27:04 - Biotech culture vs tech culture 00:32:54 - What'll it take to get biotechs to act like tech companies? 00:35:13 - *Adaptive* clinical trials 00:39:10 - "Sidebar on the FDA..." 00:43:06 - *Decentralized* trials 00:46:13 - *Who* makes clinical trials expensive? 00:48:43 - (Not) picking up the billion-dollar bills on the sidewalk 00:53:22 - What does "better" look like? 00:56:08 - "...a lot of alpha if you're willing to disregard all of this b——..." 00:58:42 - What's changing with AI? 01:00:57 - What's going on with China? 01:03:10 - What's ahead for Lindus?
1:05:12

For the first episode of Development & Research, I spoke with Meri Beckwith on: • being a patient in an incompetently-run clinical trial, • how many drug trials fail b/c of bad paperwork, • who benefits when trials are expensive, • just how quickly biotech founders lose control to investors, • why no one is picking up the billion-dollar bills on the sidewalk. Timestamps: 00:01:51 - "Eroom's Law" 00:03:12 - The gap between new science and new medicine 00:04:51 - Clinical trials: the patient experience 00:08:19 - The lifecycle of a biotech startup 00:10:22 - Clinical Research Organizations 00:13:19 - 10% of trials fail b/c of clerical errors 00:17:27 - Lindus Health (Meri's Series-B startup) 00:19:03 - Recruiting more patients won't save badly-planned trials 00:23:36 - Meri's skepticism of international trials 00:27:04 - Biotech culture vs tech culture 00:32:54 - What'll it take to get biotechs to act like tech companies? 00:35:13 - *Adaptive* clinical trials 00:39:10 - "Sidebar on the FDA..." 00:43:06 - *Decentralized* trials 00:46:13 - *Who* makes clinical trials expensive? 00:48:43 - (Not) picking up the billion-dollar bills on the sidewalk 00:53:22 - What does "better" look like? 00:56:08 - "...a lot of alpha if you're willing to disregard all of this b——..." 00:58:42 - What's changing with AI? 01:00:57 - What's going on with China? 01:03:10 - What's ahead for Lindus?

Ross Rheingans-Yoo🔸

18,066 views • 1 year ago

FDA Commissioner Dr. Marty Makary revealed a major shift at the agency that’s still making waves: “I personally meet one-on-one with reviewers and ask: ‘Are you seeing anything that gives you chills up your spine because it could be such a game-changer?’” He described the FDA’s new proactive approach: - No more passive waiting for applications. - When early data looks “too good to be true,” they call companies directly: “Forget the paperwork — send more data now.” - Fast-track vouchers for decisions in weeks instead of years. - Recent example: gene therapy restored normal hearing in 3 of 12 deaf children (improved in 7) with perfect safety — FDA contacted the company days after NEJM publication. Makary emphasized the FDA is aggressively tracking promising treatments for blindness, deafness, pediatric/rare diseases, cancers — and a “potentially promising” therapy for type 1 diabetes that has reviewers excited. This is the FDA acting like it’s on the front lines of curing disease, not just regulating it. Months later — are you hopeful this new mindset finally delivers real cures, or waiting to see hard results?
2:31

FDA Commissioner Dr. Marty Makary revealed a major shift at the agency that’s still making waves: “I personally meet one-on-one with reviewers and ask: ‘Are you seeing anything that gives you chills up your spine because it could be such a game-changer?’” He described the FDA’s new proactive approach: - No more passive waiting for applications. - When early data looks “too good to be true,” they call companies directly: “Forget the paperwork — send more data now.” - Fast-track vouchers for decisions in weeks instead of years. - Recent example: gene therapy restored normal hearing in 3 of 12 deaf children (improved in 7) with perfect safety — FDA contacted the company days after NEJM publication. Makary emphasized the FDA is aggressively tracking promising treatments for blindness, deafness, pediatric/rare diseases, cancers — and a “potentially promising” therapy for type 1 diabetes that has reviewers excited. This is the FDA acting like it’s on the front lines of curing disease, not just regulating it. Months later — are you hopeful this new mindset finally delivers real cures, or waiting to see hard results?

Camus

117,944 views • 5 months ago

NEW episode! Drug development has never been more expensive, in terms of output per dollar spent. This trend, called Eroom’s law, is surprising, considering the incredible technological advances in drug discovery, from genome sequencing to engineering to microscopy. On a new episode of the Works in Progress podcast, Ben Southwood and I talk to Ruxandra Teslo 🧬 about why this has happened and what can be done about it. We discuss how: • AI isn’t a magic bullet for drug discovery. Predictive models lack the physical human data, like individual variation and rare side effects, that can only be generated by actually running real-world clinical trials. • As scientists invent more effective drugs, it becomes harder to discover new treatments that can surpass past successes. This is known as the "Better than the Beatles" problem. • Biotech companies are increasingly moving their "first-in-human" trials to Australia because its simpler regulations allow researchers to test drug safety faster and cheaper than in the US. • Clinical trials can be made more efficient with various reforms including: embracing platform trials, allowing researchers to select from independent ethics boards, expanding the funding and validation of surrogate endpoints, increasing transparency by releasing regulatory correspondence from failed companies, and much more. Timestamps: 00:00:00 Eroom’s law and the paradox of drug development 00:08:03 How clinical trials actually work 00:10:23 The power and controversy of surrogate endpoints 00:14:01 How historical patent laws influenced trial timelines 00:22:46 The Australia advantage and regulatory drag 00:29:08 Institutional review boards (IRBs) and bureaucratic drag 00:32:21 Open science and successful reforms 00:41:49 Our wishlist for clinical trial reforms, and which reforms we *don’t* like 00:53:48 Why AI isn’t a magic bullet for drug discovery
56:13

NEW episode! Drug development has never been more expensive, in terms of output per dollar spent. This trend, called Eroom’s law, is surprising, considering the incredible technological advances in drug discovery, from genome sequencing to engineering to microscopy. On a new episode of the Works in Progress podcast, Ben Southwood and I talk to Ruxandra Teslo 🧬 about why this has happened and what can be done about it. We discuss how: • AI isn’t a magic bullet for drug discovery. Predictive models lack the physical human data, like individual variation and rare side effects, that can only be generated by actually running real-world clinical trials. • As scientists invent more effective drugs, it becomes harder to discover new treatments that can surpass past successes. This is known as the "Better than the Beatles" problem. • Biotech companies are increasingly moving their "first-in-human" trials to Australia because its simpler regulations allow researchers to test drug safety faster and cheaper than in the US. • Clinical trials can be made more efficient with various reforms including: embracing platform trials, allowing researchers to select from independent ethics boards, expanding the funding and validation of surrogate endpoints, increasing transparency by releasing regulatory correspondence from failed companies, and much more. Timestamps: 00:00:00 Eroom’s law and the paradox of drug development 00:08:03 How clinical trials actually work 00:10:23 The power and controversy of surrogate endpoints 00:14:01 How historical patent laws influenced trial timelines 00:22:46 The Australia advantage and regulatory drag 00:29:08 Institutional review boards (IRBs) and bureaucratic drag 00:32:21 Open science and successful reforms 00:41:49 Our wishlist for clinical trial reforms, and which reforms we *don’t* like 00:53:48 Why AI isn’t a magic bullet for drug discovery

Saloni

109,256 views • 4 months ago

“Vaccine deaths are a very small minority” That’s what News Nation’s Elizabeth Vargas just told FDA Commissioner Dr. Marty Makary… His response left the studio silent. Direct quotes from the interview: - “Hundreds of thousands of Americans describe vaccine injury” - “25% of clinicians I’ve surveyed know someone significantly disabled or died from the vaccine” - Makary: “I know of three people who died from the COVID vaccine through first-degree physician contacts” - Confirmed myocarditis risk in young healthy males: 1 in 2,600 - “The question isn’t ‘is it safe?’ — it’s ‘do the benefits outweigh the risks for each person?’” Then he went further: the last administration was “rubber-stamping boosters every year with NO new clinical trials.” No slogans. No conspiracy. Just a Johns Hopkins surgeon and current FDA Commissioner asking for honest, nuanced science instead of blanket mandates. Watch the full exchange below and decide for yourself. Whether you’re triple-boosted or zero doses — should we still be allowed to talk openly about benefits vs. risks without being called “anti-science”? Drop your thoughts below. Respectful replies only — this deserves real conversation.
1:11

“Vaccine deaths are a very small minority” That’s what News Nation’s Elizabeth Vargas just told FDA Commissioner Dr. Marty Makary… His response left the studio silent. Direct quotes from the interview: - “Hundreds of thousands of Americans describe vaccine injury” - “25% of clinicians I’ve surveyed know someone significantly disabled or died from the vaccine” - Makary: “I know of three people who died from the COVID vaccine through first-degree physician contacts” - Confirmed myocarditis risk in young healthy males: 1 in 2,600 - “The question isn’t ‘is it safe?’ — it’s ‘do the benefits outweigh the risks for each person?’” Then he went further: the last administration was “rubber-stamping boosters every year with NO new clinical trials.” No slogans. No conspiracy. Just a Johns Hopkins surgeon and current FDA Commissioner asking for honest, nuanced science instead of blanket mandates. Watch the full exchange below and decide for yourself. Whether you’re triple-boosted or zero doses — should we still be allowed to talk openly about benefits vs. risks without being called “anti-science”? Drop your thoughts below. Respectful replies only — this deserves real conversation.

Camus

324,232 views • 9 months ago

FDA Commissioner Marty Makary: The American food system has failed our kids “ Look at the fact that 40% of American kids have a chronic disease.” “Between the lines in the medical textbooks and medical school was kind of a blaming of children for not having the discipline, and it's not a willpower problem.” “This is highly addictive, chemicalized foods that are ultra processed, that are put in front of kids and they want more. And you put these vibrant colors in them from the petroleum-based eyes.” “And so this is something adults have done to kids.” “I think that we have failed. We've given people the wrong information, that calories in equals calories out. This demonization of fat and all that stuff we talked about.” “GLP-1s are mimicking a natural hormone in the body, and so when you get a supplementation of that, it's doing the job of increasing satiety, slowing down GI motility, and it has a profound impact on a number of conditions because you are also reducing insulin resistance and general body inflammation.” “And so, that's why we're seeing so many other benefits.” “Plus, you feel better. When you feel better, you're gonna have benefits we haven't even appreciated yet, because there's an incredible value to positive thinking.” Marty Makary MD, MPH Dr. Marty Makary
1:20

FDA Commissioner Marty Makary: The American food system has failed our kids “ Look at the fact that 40% of American kids have a chronic disease.” “Between the lines in the medical textbooks and medical school was kind of a blaming of children for not having the discipline, and it's not a willpower problem.” “This is highly addictive, chemicalized foods that are ultra processed, that are put in front of kids and they want more. And you put these vibrant colors in them from the petroleum-based eyes.” “And so this is something adults have done to kids.” “I think that we have failed. We've given people the wrong information, that calories in equals calories out. This demonization of fat and all that stuff we talked about.” “GLP-1s are mimicking a natural hormone in the body, and so when you get a supplementation of that, it's doing the job of increasing satiety, slowing down GI motility, and it has a profound impact on a number of conditions because you are also reducing insulin resistance and general body inflammation.” “And so, that's why we're seeing so many other benefits.” “Plus, you feel better. When you feel better, you're gonna have benefits we haven't even appreciated yet, because there's an incredible value to positive thinking.” Marty Makary MD, MPH Dr. Marty Makary

The All-In Podcast

46,964 views • 6 months ago

🚨 JUST IN: President Trump has nominated Dr. Heidi Overton to be the next FDA Commissioner Dr. Overton stood next to President Trump in the Oval Office just days ago, CELEBRATING Trump’s order reworking the childhood vaccine schedule TRUMP: "Today I am honored to nominate the wonderful Dr. Heidi Overton, MD, PhD, as our next FDA Commissioner. Dr. Heidi has been a ROCKSTAR in my Administration, where she has worked directly with Secretary Kennedy, Dr. Oz, and team, to deliver on the MOST TRANSFORMATIVE Health Agenda in History. She is known to take on the HARDEST issues, and bring me solutions that work best for the Country. Heidi is “ALWAYS RIGHT,” Secretary Kennedy recently said in the Oval Office! We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES. Dr. Overton was a prestigious White House Fellow in my First Term, is a Board-Certified Physician in Public Health and General Preventive Medicine, and holds a Ph.D. in Clinical Investigations from the Johns Hopkins University. She is SMART and RESPECTED by all! Dr. Heidi will work with Secretary Kennedy and Dr. Oz to RAPIDLY deliver on my priorities of FASTER Cures, INCREASED American Innovation, MAJOR Clinical Trial Reforms, LOWER Drug Prices, and even more MAHA WINS! Dr. Overton will continue putting AMERICA FIRST, and creating a HEALTHY AMERICA. Congratulations to Dr. Heidi Overton! President DONALD J. TRUMP"
2:12

🚨 JUST IN: President Trump has nominated Dr. Heidi Overton to be the next FDA Commissioner Dr. Overton stood next to President Trump in the Oval Office just days ago, CELEBRATING Trump’s order reworking the childhood vaccine schedule TRUMP: "Today I am honored to nominate the wonderful Dr. Heidi Overton, MD, PhD, as our next FDA Commissioner. Dr. Heidi has been a ROCKSTAR in my Administration, where she has worked directly with Secretary Kennedy, Dr. Oz, and team, to deliver on the MOST TRANSFORMATIVE Health Agenda in History. She is known to take on the HARDEST issues, and bring me solutions that work best for the Country. Heidi is “ALWAYS RIGHT,” Secretary Kennedy recently said in the Oval Office! We need her leadership at the FDA now to ensure that the U.S. remains the WORLD LEADER for Scientific Discovery and CURES. Dr. Overton was a prestigious White House Fellow in my First Term, is a Board-Certified Physician in Public Health and General Preventive Medicine, and holds a Ph.D. in Clinical Investigations from the Johns Hopkins University. She is SMART and RESPECTED by all! Dr. Heidi will work with Secretary Kennedy and Dr. Oz to RAPIDLY deliver on my priorities of FASTER Cures, INCREASED American Innovation, MAJOR Clinical Trial Reforms, LOWER Drug Prices, and even more MAHA WINS! Dr. Overton will continue putting AMERICA FIRST, and creating a HEALTHY AMERICA. Congratulations to Dr. Heidi Overton! President DONALD J. TRUMP"

Nick Sortor

28,607 views • 9 days ago

Big Pharma's mRNA pipe dream is collapsing as Pfizer and Moderna mod RNA trials suffer massive failures. Pfizer's mRNA FLU jab was just REJECTED by FDA commissioner Dr. Marty Makary, and Moderna's mRNA RSV trial was "paused" after 1 in 8 children "nearly died from overwhelming RSV infection". CLANCY: "They should have known [and] they shouldn't have been doing it in the first place". ◻️Pfizer & Moderna’s mRNA flu vaccines → FAILED Phase 3. ◻️Moderna’s mRNA RSV kids vaccine → PAUSED after serious safety signal. WEINSTEIN: "If you make the assumption that the people in charge of guiding these programs are actually comfortable with causing injury and death to other peoples children then it makes perfect sense".
1:40

Big Pharma's mRNA pipe dream is collapsing as Pfizer and Moderna mod RNA trials suffer massive failures. Pfizer's mRNA FLU jab was just REJECTED by FDA commissioner Dr. Marty Makary, and Moderna's mRNA RSV trial was "paused" after 1 in 8 children "nearly died from overwhelming RSV infection". CLANCY: "They should have known [and] they shouldn't have been doing it in the first place". ◻️Pfizer & Moderna’s mRNA flu vaccines → FAILED Phase 3. ◻️Moderna’s mRNA RSV kids vaccine → PAUSED after serious safety signal. WEINSTEIN: "If you make the assumption that the people in charge of guiding these programs are actually comfortable with causing injury and death to other peoples children then it makes perfect sense".

Humanspective

182,193 views • 9 months ago